8 insiders reported 32 Form 4 transactions for ATAI Life Sciences N.V. (ATAI) over the past 18 months (most recent 2026-04-22). Recent activity: Craig Kevin James (Chief Medical Officer) Buy 27,280 shares, Craig Kevin James (Chief Medical Officer) Buy 15,299 shares, Craig Kevin James (Chief Medical Officer) Sell 42,579 shares, Apeiron Investment Group Ltd. (Insider) Buy 46,070 shares, Angermayer Christian (Director) Buy 46,070 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-22 | Craig Kevin James | Chief Medical Officer | Buy | 27,280 | $40,920 |
| 2026-04-22 | Craig Kevin James | Chief Medical Officer | Buy | 15,299 | $28,150 |
| 2026-04-22 | Craig Kevin James | Chief Medical Officer | Sell | 42,579 | $212,895 |
| 2026-04-10 | Apeiron Investment Group Ltd. | Insider | Buy | 46,070 | $86,612 |
| 2026-04-10 | Angermayer Christian | Director | Buy | 46,070 | $86,612 |
| 2026-04-10 | Apeiron Investment Group Ltd. | Insider | Buy | 410,162 | $672,666 |
| 2026-04-10 | Angermayer Christian | Director | Buy | 410,162 | $672,666 |
| 2026-04-10 | Apeiron Investment Group Ltd. | Insider | Buy | 103,000 | $138,020 |
| 2026-04-10 | Angermayer Christian | Director | Buy | 103,000 | $138,020 |
| 2026-03-24 | Craig Kevin James | Chief Medical Officer | Buy | 76,224 | $89,944 |
| 2026-03-24 | Craig Kevin James | Chief Medical Officer | Buy | 23,776 | $35,664 |
| 2026-03-24 | Craig Kevin James | Chief Medical Officer | Sell | 100,000 | $355,000 |
| 2026-01-06 | Feilding-Mellen Cosmo | Director | Sell | 39,594 | $154,417 |
| 2025-11-06 | Feilding-Mellen Cosmo | Director | Buy | 7.7M | $0 |
| 2025-10-02 | Angermayer Christian | Director | Buy | 2.4M | $0 |
| 2025-10-02 | Apeiron Investment Group Ltd. | Insider | Buy | 2.4M | $0 |
| 2025-08-18 | Apeiron Investment Group Ltd. | Insider | Buy | 8.7M | $19.0M |
| 2025-08-18 | Angermayer Christian | Director | Buy | 8.7M | $19.0M |
| 2025-03-24 | Kirpekar Sahil | Chief Business Officer | Sell | 48,563 | $65,560 |
| 2025-03-24 | Apeiron Investment Group Ltd. | Insider | Buy | 1.8M | $2.5M |
| 2025-03-24 | Angermayer Christian | Director | Buy | 1.8M | $2.5M |
| 2025-03-24 | Craig Kevin James | Chief Medical Officer | Sell | 11,563 | $15,610 |
| 2025-03-24 | Short Glenn Frank | Chief Scientific Officer | Sell | 13,161 | $17,767 |
| 2025-03-24 | Rao Srinivas | See Remarks | Sell | 75,418 | $101,814 |
| 2025-03-24 | Johnson Anne Nagengast | Chief Financial Officer | Sell | 33,545 | $45,286 |
Source: SEC Form 4 filings · as of 2026-04-22